Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chinese clinical practice guidelines for ultrasound-guided irreversible electroporation of liver cancer (version 2022).
Xu M, Xie LT, Xiao YY, Liang P, Zhao QY, Wang ZM, Chai WL, Wei YT, Xu LF, Hu XK, Kuang M, Niu LZ, Yao CG, Kong HY, Tian G, Xie XY, Cui XW, Xu D, Zhao J, Jiang TA; Interventional Diagnosis and Treatment Group of the Ultrasonic Medicine Branch of Chinese Medical Association; Nanoknife Tumor Ablation Society of the Interventional Minimally Invasive Therapy Special Committee of China Medicine Education Association. Xu M, et al. Among authors: wang zm. Hepatobiliary Pancreat Dis Int. 2022 Oct;21(5):462-471. doi: 10.1016/j.hbpd.2022.08.006. Epub 2022 Sep 2. Hepatobiliary Pancreat Dis Int. 2022. PMID: 36058782 No abstract available.
Guidelines for permanent iodine-125 seed interstitial brachytherapy for pancreatic cancer (2023 edition): The Chinese expert consensus workshop report.
Liu B, Huang W, Zhang F, Wang J, Guo J, Huang X, Lei G, Wang J, Ye X, Wang R, Gai B, Hu X, Li M, Li C, Xiao Y, Lin Z, Niu L, Zhu G, Gao F, Niu H, Zhang H, Wu Q, Yang J, Zhao H, Zhang K, Chen Z, Chen T, Zhang H, Wang Z, Li Y. Liu B, et al. J Cancer Res Ther. 2024 Aug 1;20(4):1124-1129. doi: 10.4103/jcrt.jcrt_2368_23. Epub 2024 Aug 29. J Cancer Res Ther. 2024. PMID: 39206973 Free article.
Chinese expert consensus on the nursing management of the totally implantable venous access device.
Xu Y, Fei XY, Xue YH, Wang XM, Wang XY, Zheng YT, Chen K, He JJ, Ren XH, Pan L, Wang L, Qian D, Li WF, Liang Y, Fang Y, Huang XF, Li CH, Chen DP, Wang Y, Wen LH, Zhang YH, Zheng Y, Song H, Lin YC, Zhang Q, Yang RM, Wang ZM. Xu Y, et al. Among authors: wang l, wang xy, wang y, wang zm, wang xm. J Cancer Res Ther. 2022 Sep;18(5):1231-1240. doi: 10.4103/jcrt.jcrt_387_22. J Cancer Res Ther. 2022. PMID: 36204867 Free article. Review.
Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial.
HARMONi-A Study Investigators; Fang W, Zhao Y, Luo Y, Yang R, Huang Y, He Z, Zhao H, Li M, Li K, Song Q, Du X, Sun Y, Li W, Xu F, Wang Z, Yang K, Fan Y, Liu B, Zhao H, Hu Y, Jia L, Xu S, Yi T, Lv D, Lan H, Li M, Liang W, Wang Y, Yang H, Jia Y, Chen Y, Lu J, Feng J, Liu C, Zhou M, Zhou J, Liu X, Zhou N, He M, Dong X, Chen H, Chen Y, Su H, Li X, Zhang Z, Yang L, Cheng Y, Chen L, Hou X, Zhang Y, Guo J, Wang Z, Lu H, Wu D, Feng W, Li W, Huang J, Wang Y, Song X, Peng J, Liu L, Guo Y, Li W, Lu D, Hu M, Wang ZM, Li B, Xia M, Zhang L. HARMONi-A Study Investigators, et al. Among authors: wang z, wang y, wang zm. JAMA. 2024 Aug 20;332(7):561-570. doi: 10.1001/jama.2024.10613. JAMA. 2024. PMID: 38820549 Clinical Trial.
[Treatment of AIDS patients with Chinese medicinal herbs qudu zengning capsule].
Li ZL, Wang ZM, Liu XZ, Zhang ZS, Wang Z, Ma SW, Chen CH, Xue XL, Wen RX, Yue YC, Zhu XP, Zeng Y. Li ZL, et al. Among authors: wang z, wang zm. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Dec;18(4):305-7. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004. PMID: 15650775 Chinese.
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China.
Wu X, Sun Y, Yang H, Wang J, Lou H, Li D, Wang K, Zhang H, Wu T, Li Y, Wang C, Li G, Wang Y, Li D, Tang Y, Pan M, Cai H, Wang W, Yang B, Qian H, Tian Q, Yao D, Cheng Y, Wei B, Li X, Wang T, Hao M, Wang X, Wang T, Ran J, Zhu H, Zhu L, Liu X, Li Y, Chen L, Li Q, Yan X, Wang F, Cai H, Zhang Y, Liang Z, Liu F, Huang Y, Xia B, Qu P, Zhu G, Chen Y, Song K, Sun M, Chen Z, Zhou Q, Hu L, Abulizi G, Guo H, Liao S, Ye Y, Yan P, Tang Q, Sun G, Liu T, Lu D, Hu M, Wang ZM, Li B, Xia M. Wu X, et al. Among authors: wang x, wang w, wang f, wang k, wang j, wang y, wang zm, wang t, wang c. Lancet. 2024 Oct 26;404(10463):1668-1676. doi: 10.1016/S0140-6736(24)02135-4. Epub 2024 Oct 16. Lancet. 2024. PMID: 39426385 Clinical Trial.
1,679 results